SCHEMBL2780672

SCHEMBL2780672

CCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OC1CCOCC1.COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OC1CCN(CCNC(C)=O)CC1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERBB2 P04626 3/20 0.67
EGFR P00533 18/20 0.66
RET P07949 2/20 0.64
ERBB4 Q15303 2/20 0.64
MST1R Q04912 1/20 0.64
BRAF P15056 2/20 0.62
CIT O14578 1/20 0.62
GAK O14976 1/20 0.62
EPHB6 O15197 1/20 0.62
ABCC4 O15439 1/20 0.62
DAPK3 O43293 1/20 0.62
RIPK2 O43353 1/20 0.62
NR1I2 O75469 1/20 0.62
RPS6KA4 O75676 1/20 0.62
STK17B O94768 1/20 0.62
STK10 O94804 1/20 0.62
PRKD3 O94806 1/20 0.62
ABCB11 O95342 1/20 0.62
MAP4K4 O95819 1/20 0.62
CHEK2 O96017 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL120193 0.93 ERBB2 (0.76) ERBB2EGFRRETERBB4MST1R
SCHEMBL29623446 0.93 ERBB2 (0.76) ERBB2EGFRRETERBB4MST1R
SCHEMBL12743433 0.89 ERBB2 (0.74) ERBB2EGFRRETERBB4BRAF
SCHEMBL4428930 0.88 ERBB2 (0.70) ERBB2EGFRRETERBB4MST1R
SCHEMBL4422322 0.88 ERBB2 (0.73) ERBB2EGFRRETERBB4MST1R
SCHEMBL12743425 0.87 ERBB2 (0.77) ERBB2EGFR
SCHEMBL4422754 0.87 ERBB2 (0.77) ERBB2EGFRRETERBB4MST1R
SCHEMBL185411 0.86 EGFR (0.66) ERBB2EGFRRETERBB4MST1R
SCHEMBL29623544 0.86 EGFR (0.66) ERBB2EGFRRETERBB4MST1R
SCHEMBL12743429 0.85 ERBB2 (0.73) ERBB2EGFRRETERBB4MST1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2393492-A1 NEW PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF RESPIRATORY AND GASTROINTESTINAL DISORDERS Boehringer Ingelheim International GmbH (DE) 2011-12-14 EP disclosed
WO-2010089391-A1 NEW PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF RESPIRATORY AND GASTROINTESTINAL DISORDERS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-08-12 WO disclosed
EP-2011536-A1 Inhaler Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2009-01-07 EP disclosed